NYSE: TFX

Teleflex Incorporated

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Teleflex Incorporated (NYSE: TFX) resulting from allegations that Teleflex may have issued materially misleading business information to the investing public.

If you purchased Teleflex securities and would like to join the prospective action, please click “Join This Class Action.”

Retainer Agreement
See Full Details
Join This Class Action
If you purchased Teleflex securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Contact Us

Details of investigation:

On February 27, 2025, during market hours, Fierce Biotech published an article entitled “Teleflex plays musical chairs, plans company split amid €760M Biotronik cardiovascular deal.” The article stated that “Teleflex has announced a plan to split its business into two separate independent companies—and it’s setting up one of its future scions with a new portfolio of cardiovascular device assets, set to be acquired from Biotronik.”

On this news, Teleflex stock fell $38.52 per share, or 21.6%, to close at $139.11 on February 27, 2025.

Follow us on:
Twitter
Company Name: Teleflex Incorporated
Stock Symbol: TFX
Class Period: N/A
Court: N/A
Share This Class Action
Join This Class Action

Why Rosen Law

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Case Attorneys

image 55 (1)
Phillip Kim

New York, Philadelphia Metro

275 Madison Avenue
40th Floor
New York, NY 10016

Tel: (212) 686-1060
Rosenlegal
Scroll to Top